Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
– Sell
-4,593
Closed -$456K – 309
2019
Q3
$456K Sell
4,593
-194
-4% -$18.4K 0.08% 129
2019
Q2
$443K Buy
4,787
+1,265
+36% +$120K 0.09% 121
2019
Q1
$332K Buy
+3,522
New +$308K 0.08% 131
2017
Q3
– Sell
-1,576
Closed -$205K – 100
2017
Q2
$205K Buy
+1,576
New +$193K 0.08% 89

Other funds holding CELG

Clarius Group's CELG Position: Q4 2019 in Review

Clarius Group sold out of Celgene (CELG) in Q4 2019, closing a stake of 4,593 shares — an estimated $456K sold.

Clarius Group first reported a position in CELG in Q2 2017 and held it in 4 quarters. The position peaked at $456K in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Clarius Group reported no remaining Celgene position as of Q4 2019 after selling out during the quarter.
  • Clarius Group sold 4,593 Celgene shares in Q4 2019, an estimated $456K.
  • Clarius Group first reported a position in Celgene in Q2 2017 and held it in 4 quarters.
  • Clarius Group's Celgene position peaked at $456K in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene as of Q4 2019.

Based on Clarius Group's 13F filing for Q4 2019, filed 22 Jan 2020.